Home | News | Find a Doctor | Ask a Question | Free

Aderans aquires ICX TRC


#1

I just recieved an update auto email from ICX web bot. The email enstates that Aderans bought TRC for the sum of $200,000.

What do you all make of this?


#2

» I just recieved an update auto email from ICX web bot. The email enstates
» that Aderans bought TRC for the sum of $200,000.
»
» What do you all make of this?

in my oppinion that is quite exciting…!! Aderans must be on to something if they feel the need to acquire more facilities… hope to hear other peoples oppinions!


#3

» » I just recieved an update auto email from ICX web bot. The email
» enstates
» » that Aderans bought TRC for the sum of $200,000.
» »
» » What do you all make of this?
»
» in my oppinion that is quite exciting…!! Aderans must be on to something
» if they feel the need to acquire more facilities… hope to hear other
» peoples oppinions!

It could mean anything. They could have bought ICX’s lab equipment, or maybe they acquired their patents. The ICX patents might have been close enough to Aderan’s that they were worried a competitor could have purchased them and threatened ARI’s product. It is positive, however, that Aderans feels there’s a reason to purchase anything - I don’t think they’d waste the capital if they didn’t have a reason to do so.


#4

» » » I just recieved an update auto email from ICX web bot. The email
» » enstates
» » » that Aderans bought TRC for the sum of $200,000.
» » »
» » » What do you all make of this?
» »
» » in my oppinion that is quite exciting…!! Aderans must be on to
» something
» » if they feel the need to acquire more facilities… hope to hear other
» » peoples oppinions!
»
» It could mean anything. They could have bought ICX’s lab equipment, or
» maybe they acquired their patents. The ICX patents might have been close
» enough to Aderan’s that they were worried a competitor could have purchased
» them and threatened ARI’s product. It is positive, however, that Aderans
» feels there’s a reason to purchase anything - I don’t think they’d waste
» the capital if they didn’t have a reason to do so.

That’s true, however $200,000 is not really a whole lot of money… never the less… as long as they keep investing money in this field they must believe they are on to something… or at least they dont seem to think that its a hopeless endeavour.


#5

Many options are open depending on what they have bought: intellectual properties, assets etc. If they have bought assets, it is a good sign, because it means they are expanding their business. If they have bought intellectual properties I would not be so optimistic about it. What if they were just looking for ideas? It would mean they have run out of their own. And by the way, 200000$ it’s not big money.

We do not have enough elements to judge. I keep my finger crossed.

» » » » I just recieved an update auto email from ICX web bot. The email
» » » enstates
» » » » that Aderans bought TRC for the sum of $200,000.
» » » »
» » » » What do you all make of this?
» » »
» » » in my oppinion that is quite exciting…!! Aderans must be on to
» » something
» » » if they feel the need to acquire more facilities… hope to hear
» other
» » » peoples oppinions!
» »
» » It could mean anything. They could have bought ICX’s lab equipment, or
» » maybe they acquired their patents. The ICX patents might have been
» close
» » enough to Aderan’s that they were worried a competitor could have
» purchased
» » them and threatened ARI’s product. It is positive, however, that
» Aderans
» » feels there’s a reason to purchase anything - I don’t think they’d
» waste
» » the capital if they didn’t have a reason to do so.
»
» That’s true, however $200,000 is not really a whole lot of money… never
» the less… as long as they keep investing money in this field they must
» believe they are on to something… or at least they dont seem to think that
» its a hopeless endeavour.


#6

Remember Aderans or Bosley already paid a large sum to acquire the licensing or distribution rights already many years ago when Intercytex first started doing their trials, now they keep pumping more money into this research?


#7

guys $200,000 is really not much money at all, in fact it is a joke. any company with any chance at all helping cure hair loss is going to be worth a lot more than $200,000 In my opinion. alec


#8

» Many options are open depending on what they have bought: intellectual
» properties, assets etc. If they have bought assets, it is a good sign,
» because it means they are expanding their business. If they have bought
» intellectual properties I would not be so optimistic about it. What if they
» were just looking for ideas? It would mean they have run out of their own.
» And by the way, 200000$ it’s not big money.
»
» We do not have enough elements to judge. I keep my finger crossed.

It IS all about intellectual properties, because Intercytex has been one of the first, who filed a patent (2002) for cell injections against hairloss.

First “milestone payment” in 2007 (US$200,000 received from Bosley under ICX-TRC option):
http://www.intercytex.com/icx/news/releases/2008/2008-03-18/

Aderans just tries to get as much ground as possible in regard intellectual properties. Or did you thought Aderans bought Intercytex’s Petri dishes or their lab mice?


#9

The lab mice, obviously XD

Anyway, what could be the reason of buying the patent of a technique that never proved to be working? Am I missing anything?

» » Many options are open depending on what they have bought: intellectual
» » properties, assets etc. If they have bought assets, it is a good sign,
» » because it means they are expanding their business. If they have bought
» » intellectual properties I would not be so
» optimistic about it. What if they
» » were just looking for ideas? It would mean they have run out of their
» own.
» » And by the way, 200000$ it’s not big money.
» »
» » We do not have enough elements to judge. I keep my finger crossed.
»
» It IS all about intellectual properties, because Intercytex has
» been one of the first, who filed a patent (2002) for cell injections
» against hairloss.
»
» First “milestone payment” in 2007 (US$200,000 received from Bosley under
» ICX-TRC option):
» http://www.intercytex.com/icx/news/releases/2008/2008-03-18/
»
» Aderans just tries to get as much ground as possible in regard
» intellectual properties. Or did you thought Aderans bought Intercytex’s
» Petri dishes or their lab mice?


#10

I don’t think that was a web bot, it was actually probably a human. Since they gave other members, and myself specific info regarding individual questions we asked. That might not be a lot of money for a big company but they usually dont want to piss away a cent either. Whatever it is they must think it’s worth it. Good news though if their being agressive like this (I hope).


#11

» I just recieved an update auto email from ICX web bot. The email enstates
» that Aderans bought TRC for the sum of $200,000.
»
» What do you all make of this?

We could have pooled this much money ourselves :stuck_out_tongue:


#12

» I just recieved an update auto email from ICX web bot. The email enstates
» that Aderans bought TRC for the sum of $200,000.
»
» What do you all make of this?

ewwww, TRC is worth less than a few hair transplants.


#13

» ewwww, TRC is worth less than a few hair transplants.

Correct. That is the reason why Aderans bought the ICX-TRC assets. Well, you have to know, Aderans simply have too much money, because ARI Inc. earned a lot of money during the past 8 years. Therefore they sometimes have absolutely no idea where they could spend it.


#14

» » ewwww, TRC is worth less than a few hair transplants.
»
» Correct. That is the reason why Aderans bought the ICX-TRC assets. Well,
» you have to know, Aderans simply have too much money, because ARI Inc.
» earned a lot of money during the past 8 years. Therefore they sometimes
» have absolutely no idea where they could spend it.

lol… you cant be serious… i REALLY don’t think the reason they bought ICX-TRC is simply because they dont know how else to spend it. As all corporations they will invest their money on assets they think will be profitable in the future… so on assets they deem “well invested” and not simply because they are floating in money…


#15

» » » ewwww, TRC is worth less than a few hair transplants.
» »
» » Correct. That is the reason why Aderans bought the ICX-TRC assets.
» Well,
» » you have to know, Aderans simply have too much money, because ARI Inc.
» » earned a lot of money during the past 8 years. Therefore they sometimes
» » have absolutely no idea where they could spend it.
»
» lol… you cant be serious… i REALLY don’t think the reason they bought
» ICX-TRC is simply because they dont know how else to spend it. As all
» corporations they will invest their money on assets they think will be
» profitable in the future… so on assets they deem “well invested” and not
» simply because they are floating in money…

I totally agree. Aderans wouldn’t just throw away $200,000 for no reason. They must either think they have something to gain or something they can protect by buying ICX-TRC


#16

Well, it is logical that ARI buys TRC, because there was already a relationship between ARI and ICX. Milestone payments to ICX, and a distribution agreement through Bosley.
And the price is so low, that even if the patents are worthless, the lab equipment could be enough to justify the purchase. I don’t know if the price also includes real state (buildings, rooms), I don’t think so, for such a low price…
Also, as fckhrls has suggested, by taking the patents, ARI prevents the potential risk that others could use these patents against them. “Patent speculation”.

» » » ewwww, TRC is worth less than a few hair transplants.
» »
» » Correct. That is the reason why Aderans bought the ICX-TRC assets.
» Well,
» » you have to know, Aderans simply have too much money, because ARI Inc.
» » earned a lot of money during the past 8 years. Therefore they sometimes
» » have absolutely no idea where they could spend it.
»
» lol… you cant be serious… i REALLY don’t think the reason they bought
» ICX-TRC is simply because they dont know how else to spend it. As all
» corporations they will invest their money on assets they think will be
» profitable in the future… so on assets they deem “well invested” and not
» simply because they are floating in money…


#17

Now I am thinking… probably, the lab equipment and real state allocated to TRC is not significant. The clinical trials were conducted in very few trialists, along 5 or more years, so I think little lab resources can suffice for that.

So, now I would say ARI paid for the patents. And the trials’ data, and all the research, publications, etc. Intellectual property.

» Well, it is logical that ARI buys TRC, because there was already a
» relationship between ARI and ICX. Milestone payments to ICX, and a
» distribution agreement through Bosley.
» And the price is so low, that even if the patents are worthless, the lab
» equipment could be enough to justify the purchase. I don’t know if the
» price also includes real state (buildings, rooms), I don’t think so, for
» such a low price…
» Also, as fckhrls has suggested, by taking the patents, ARI prevents the
» potential risk that others could use these patents against them. “Patent
» speculation”.


#18

You are all wrong, this is strictly a business decision, Aderans bought TRC so that they can eliminate potential competition in case some other companies decide to acquire ICX technology and pick up from where they left off, that would become a huge threat to Aderans. This is a business decision and I think it’s a small price to pay to have peace of mind.


#19

» Now I am thinking

Ah, he stopped smoking Crack for awhile …


#20

I agree that this was probably just a purchase of the TRC patents to keep them out of anyone else’s hands. In terms of intellectual property rights, the TRC patents were probably the closest thing to a weakness that ARI has. With ICX going down the toilet there was good chance someone else could buy them if ARI didn’t.